| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bioxcel Therapeutics, Inc. (BTAI) has 11 insiders with recent SEC Form 4 filings, including 8 buys and 0 sells. BTAI is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 17.0K | $20.2K | - | |
| Dir | 17.0K | $20.2K | - | |
| Dir | 17.0K | $20.2K | - | |
| Dir | 17.0K | $20.2K | - | |
| Dir | 17.0K | $20.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2018 | Mehta Vimal92 | CEO, President, Secretary | Buy | 1,000 | $5.10 | $5,104.00 | +62.5% | |
| Nov 29, 2018 | Yocca Frank88 | Chief Scientific Officer | Buy | 500 | $5.02 | $2,511.15 | New | |
| Nov 29, 2018 | Steinhart Richard I87 | Chief Financial Officer | Buy | 500 | $5.00 | $2,500.00 | New | |
| Nov 29, 2018 | Nandabalan Krishnan75 | Director, 10% Owner | Buy | 1,000 | $4.92 | $4,915.00 | New | |
| Mar 12, 2018 | Mehta Vimal92 | CEO, President And Secretary | Buy | 2,000 | $11.00 | $22,000.00 | New |